Description

3,5-Dimethyl-3'-[8-(1,4-Dioxa-8-Azaspiro[4.5]Decyl)Methyl]Benzophenone is a high-purity, advanced pharmaceutical intermediate featuring a complex molecular architecture. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting central nervous system disorders. It is essential for research institutions and pharmaceutical manufacturers engaged in the development of next-generation therapeutics, where precise chemical structure and reliable purity are paramount for successful outcomes.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of complex drug molecules, especially in neurological and psychiatric drug research.
• Organic Synthesis Building Block: Utilized in academic and industrial R&D for constructing complex heterocyclic and spirocyclic compounds.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and the discovery of new biological entities.
• Process Chemistry Development: Used in scaling up synthetic routes from laboratory to pilot plant and commercial production.
• Reference Standard: Employed as an analytical standard for quality control and method validation in API manufacturing.

Basic Information

Product Name	3,5-Dimethyl-3'-[8-(1,4-Dioxa-8-Azaspiro[4.5]Decyl)Methyl]Benzophenone
CAS No.	898761-91-6
Molecular Formula	C24H29NO3
Molecular Weight	379.50 g/mol
Synonyms	3,5-Dimethyl-3'-[8-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)methyl]benzophenone; 3'-(1,4-Dioxa-8-azaspiro[4.5]dec-8-ylmethyl)-3,5-dimethylbenzophenone; 3,5-Dimethyl-3'-(1,4-dioxa-8-azaspiro[4.5]decan-8-ylmethyl)benzophenone; Benzophenone, 3,5-dimethyl-3'-[8-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)methyl]-; 898761-91-6; Spirocyclic benzophenone derivative; 8-[(3,5-Dimethylbenzoyl)benzyl]-1,4-dioxa-8-azaspiro[4.5]decane
EINECS	Contact for details

Quality Control

Our 3,5-Dimethyl-3'-[8-(1,4-Dioxa-8-Azaspiro[4.5]Decyl)Methyl]Benzophenone is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our production adheres to cGMP guidelines where applicable, ensuring the material meets the stringent requirements for pharmaceutical development and manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to prevent moisture absorption. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.